FIRST WORLDWIDE REAL-LIFE DATA ON FIXED-DURATION IBRUTINIB+VENETOCLAX TREATMENT FOR PREVIOUSLY UNTREATED CLL/SLL PATIENTS: INITIAL INTERIM ANALYSIS OF SPAIN´S LI+VE OBSERVATIONAL STUDY

EHA Library, JOSE ANGEL HERNANDEZ RIVAS, 4160654

FIXED-DURATION BTKI-VENETOCLAX COMBINATIONS IN CLL: AN INDIRECT COMPARISON OF AMPLIFY AND CAPTIVATE TRIALS

EHA Library, Stefano Molica, 4160655

COMPARATIVE EFFICACY OF ZANUBRUTINIB VERSUS FIXED-DURATION ACALABRUTINIB PLUS VENETOCLAX FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC)

EHA Library, Talha Munir, 4160656

GENOTYPING OF SLC22A4 SNP RS460089 IN A REAL-LIFE CML COHORT: IMPLICATIONS FOR IMATINIB RESPONSE AND STABLE DMR ACHIEVEMENT

EHA Library, Katerina Machova, 4160657

OVERCOMING ASCIMINIB RESISTANCE IN CHRONIC MYELOID LEUKEMIA WITH IDENTIFICATION OF THERAPEUTIC STRATEGIES TARGETING BCR::ABL1 MUTATIONS

EHA Library, Seiichi Okabe, 4160658

LOW SERUM IL-8 MAY CONTRIBUTES TO TREATMENT-FREE REMISSION IN CHRONIC MYELOID LEUKEMIA

EHA Library, Yuki Fujioka, 4160659

GERMLINE VARIANTS IN PEDIATRIC CHRONIC MYELOID LEUKEMIA

EHA Library, Tabita Ghete, 4160660

EARLY PREDICTION OF MR4.5 ATTAINMENT AND SUSTAINED RESPONSE IN CHRONIC MYELOID LEUKEMIA TREATED WITH SECOND-GENERATION TYROSINE KINASE INHIBITORS: ANALYSIS FROM THE JALSG CML212 ROAD TO MR4.5 STUDY

EHA Library, TAKAAKI ONO, 4160661

PROSPECTIVE VALIDATION OF A DNA/RNA MRD-BASED RISK STRATIFICATION MODEL DURING TWO-PHASE TKI DOSE DE-ESCALATION FOR DISCONTINUATION IN CML

EHA Library, Katerina Machova, 4160662

IMPROVED PATIENT-REPORTED OUTCOMES (PROS) WITH ASCIMINIB (ASC) VS INVESTIGATOR-SELECTED TYROSINE KINASE INHIBITORS (IS-TKIS) IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA (CML): ASC4FIRST WK 48 ANALYSIS

EHA Library, Andreas Hochhaus, 4160663

RESULTS FROM THE FIRST-IN-CHILD PHASE II TRIAL (ITCC-054/COG-AAML1921) OF BOSUTINIB IN PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED (ND) CHRONIC MYELOID LEUKEMIA (CML).

EHA Library, Kim Schellekens, 4160664

ASSESSMENT OF TRANSITIONING FROM HIGH-POTENCY TO LOW-POTENCY INHIBITORS IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS: THE DOWNGRADING-IMPACT (D-IMPACT) PROJECT, A CML CAMPUS STUDY

EHA Library, Simona Bernardi, 4160665

THE FRONTLINE SECOND GENERATION TYROSINE KINASE INHIBITORS BRING TREATMENT-FREE REMISSION TO MORE PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Naoto Takahashi, 4160666

MYELOPROLIFERATIVE NEOPLASMS WITH CONCOMITANT CHRONIC MYELOID LEUKAEMIA ARE ASSOCIATED WITH TKI RESISTANCE AND POOR OUTCOMES: A REVIEW OF 46 CASES

EHA Library, Laura Li Gagnon, 4160667

ASC4OPT STUDY: HIGH EFFICACY AND FAVORABLE TOLERABILITY OF ASCIMINIB ONCE OR TWICE DAILY IN CML PATIENTS WITH SUBOPTIMAL RESPONSE, RESISTANCE OR INTOLERANCE OF 2 OR MORE TYROSINE KINASE INHIBITORS

EHA Library, Andreas Hochhaus, 4160668

UPDATED RESULTS OF MANAGED-ACCESS PROGRAM (MAP) OF ASCIMINIB USE IN CHRONIC MYELOID LEUKEMIA PATIENTS IN 3 CLINICAL CENTERS.

EHA Library, Ekaterina Chelysheva, 4160669

IMPACT OF ADVERSE EVENTS ON QUALITY OF LIFE IN CHRONIC MYELOID LEUKEMIA (CML) - RESULTS FROM THE PATIENT SURVEY ON HUMANISTIC BURDEN OF INTOLERANCE TO FIRST OR SECOND TKIS (SHIFT) STUDY IN THE US

EHA Library, David Wei, 4160670

CLINICAL FEATURES AND T CELL REPERTOIRE OF CHRONIC MYELOID LEUKEMIA PATIENTS WHO ATTEMPT DISCONTINUATION OF TYROSINE KINASE INHIBITORS: THE ISAC-TFR STUDY

EHA Library, Mai Fujita, 4160671

DEVELOPMENT OF A NOVEL SCORING TOOL TO PREDICT OPTIMAL RESPONSE IN CHRONIC MYELOID LEUKEMIA FOR IMPROVING TREATMENT EFFICACY BEYOND CURRENT RISK CLASSIFICATIONS

EHA Library, Kohjin Suzuki, 4160672

IMPACT OF PONATINIB TREATMENT ON PREGNANCY OUTCOMES

EHA Library, Elisabetta Abruzzese, 4160673

ANALYSIS OF FACTORS INFLUENCING TREATMENT-FREE REMISSION OUTCOMES AFTER IMATINIB DISCONTINUATION IN PAEDIATRIC CHRONIC MYELOID LEUKEMIA

EHA Library, Yanli Zhang, 4160674

SINGLE-CELL DERIVED TRANSCRIPTIONAL SIGNATURE OF DYSERYTHROPOIESIS STRATIFIES MDS WITH DIFFERENTIAL OUTCOMES AND RESPONSE TO LUSPATERCEPT

EHA Library, Kristian Gurashi, 4160675

TREATMENT ASSOCIATED CLONAL EVOLUTION IN HR-MDS AND AML- COMPREHENSIVE PROFILING IDENTIFIES BIOMARKERS AND TARGETABLE MECHANISMS OF ESCAPE

EHA Library, Paolo Mazzeo, 4160676

GALECTIN-1 AS A POTENTIAL NOVEL THERAPEUTIC TARGET IN CHRONIC MYELOMONOCYTIC LEUKAEMIA

EHA Library, Laura Guest, 4160677

EVALUATION OF EFFICACY AND SAFETY OF AVATROMBOPAG IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA BASED ON DISEASE DURATION: RESULTS FROM THE AVATROMBOPAG PHASE 3-B PEDIATRIC TRIAL

EHA Library, Rachael Grace, 4161324

THE ROLE OF SYMPATHETIC NERVE REGULATION IN MEGAKARYOCYTE FUNCTION AND PLATELET PRODUCTION IN IMMUNE THROMBOCYTOPENIA

EHA Library, Menglin Li, 4161325

IL-1ß INDUCE CAR-T-ASSOCIATED COAGULOPATHY VIA THE HSP90/KALLIKREIN/UPA PATHWAY

EHA Library, Heng Mei, 4161326

SUSCEPTIBILITY TO BLEEDING IN ITP IS NOT INCREASED IN ELDERLY PATIENTS: EVIDENCE FROM THE UK ITP REGISTRY

EHA Library, Frederick Chen, 4161327

PHASE I AND III STUDY RESULTS OF RECOMBINANT HUMAN COAGULATION FACTOR VIIA (TQG203):PHARMACOKINETICS/PHARMACODYNAMICS,EFFICACY AND SAFETY OF TQG203 IN HEMOPHILIA PATIENTS WITH INHIBITORS

EHA Library, Lei Zhang, 4161328

ARVENACOGENE SANPARVOVEC, A NOVEL OPTION FOR HEMOPHILIA B GENE THERAPY: FIRST-IN-HUMAN FINDINGS

EHA Library, Nadezhda Zozulya, 4161329

AN OBSERVATIONAL STUDY TO DESCRIBE THE IMPACT AND BURDEN OF NON-SEVERE HEMOPHILIA A FROM THE PATIENT'S PERSPECTIVE IN SPAIN: LEMON STUDY

EHA Library, MANUEL RODRIGUEZ LOPEZ, 4161330

EFFICACY OF IANALUMAB IN A MOUSE MODEL OF AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)

EHA Library, Karina Yazdanbakhsh, 4161331

THE MAASTRICHT BLEEDING COHORT: PHENOTYPIC AND GENOTYPIC INSIGHTS INTO GENDERED PATTERNS OF BLEEDING DISORDERS

EHA Library, Nienke Meskes, 4161332

FACTORS INFLUENCING THE CHOICE OF ROMIPLOSTIM OR ELTROMBOPAG IN IMMUNE THROMBOCYTOPENIA: INSIGHTS FROM A REAL-WORLD EUROPEAN COHORT

EHA Library, Maria Lozano, 4161333

ALK1-BMPRII RECEPTOR AGONISM TREATS VASCULAR PATHOLOGY IN HEREDITARY HEMORRHAGIC TELANGIECTASIA MODELS

EHA Library, Melissa Geddie, 4161334

ASSESSMENT OF NOVEL POINT-OF-CARE WHOLE BLOOD COAGULATION ASSAY TO EVALUATE COAGULATION RESPONSE TO BIAB FVIIIA MIMETIC AND FVIII THERAPY

EHA Library, Christina Higgins, 4161335

ANAEMIA, IRON DEFICIENCY, AND HAEMOLYSIS IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA

EHA Library, Justin Oosterlee, 4161336

ONLINE MEDICAL EDUCATION RESULTS IN PRACTICE CHANGES AND IDENTIFIES BARRIERS IN CONSIDERING PROPHYLAXIS FOR PATIENTS WITH MODERATE HEMOPHILIA A WITH A SEVERE BLEEDING PHENOTYPE

EHA Library, S Christy Rohani-Montez, 4161337

THE PRESENCE OF HEMORRHAGIC SYNDROME IN ACUTE MYELOID LEUKEMIA PATIENTS WITH THROMBOCYTOPENIA

EHA Library, Vira Barilka, 4161338

CLINICAL AND GENETIC ANALYSIS OF CONGENITAL FIBRINOGEN DISORDERS IN CHINESE PATIENTS: IDENTIFICATION OF SEVEN NOVEL MUTATIONS

EHA Library, Yuxiu Chen, 4161339

PROGNOSTIC ACCURACY OF THE DIFFERENT SCORING SYSTEMS FOR ASSESSING MORTALITY IN SEPSIS

EHA Library, Gülçin Çelebi, 4161340

A RISK ASSESSMENT MODEL THAT INCORPORATES THROMBOINFLAMMATION BIOMARKERS ENHANCES THE ABILITY TO PREDICT EARLY DISEASE PROGRESSION IN ADVANCED-STAGE NON-SMALL CELL LUNG CANCER PATIENTS

EHA Library, Patricia Gomez-Rosas, 4161341

EFFECTS OF THROMBOPOIETIN AND THROMBOPOIETIN RECEPTOR AGONISTS ON PLATELET ACTIVATION AND THROMBOSIS

EHA Library, Fan Zhou, 4161342

THE UTILITY OF URINE QUALITATIVE ASSESSMENT FOR DIRECT ORAL ANTICOAGULANTS IN ROUTINE CLINICAL PRACTICE

EHA Library, Francesca Schieppati, 4161343

HIGH RISK OF RECURRENT VENOUS THROMBOEMBOLISM WITHIN TWO YEARS OF THE FIRST EPISODE IN PATIENTS WITH LYMPHOMA DESPITE ANTICOAGULATION

EHA Library, Ingrid Lundahl, 4161344

IDENTIFICATION OF NEW MOLECULAR MECHANISMS OF ANTITHROMBIN DEFICIENCY: RESULTS FROM A POLISH COHORT

EHA Library, Anetta Undas, 4161345

EASIX, A NEW TOOL TO PREDICT RESPONSE AND REFRACTORINESS IN IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA?

EHA Library, Maria Queralt Salas, 4161346

PHENOTYPING THE INTRINSIC THROMBIN GENERATION IN PLASMA SAMPLES CONTAINING HEPARIN: THE CASE OF TINZAPARIN NEUTRALIZATION.

EHA Library, Emilie Chalayer, 4161347

FACTORS RELATED TO ADHERENCE TO DIRECT ORAL ANTICOAGULANTS: IMPACT OF CLINICAL OUTPATIENT FOLLOW-UP

EHA Library, Maricel Subira, 4161348

EFFECT OF PROC GENE VARIANTS ON VENOUS THROMBOSIS: A RETROSPECTIVE CASE-CONTROL STUDY IN TAIWANESE POPULATION

EHA Library, Chi-yen Chen, 4161349

RELATIONSHIP BETWEEN PODOPLANIN EXPRESSION IN COVID-19 INFECTED PATIENTS AND THE INCIDENCE OF THROMBOTIC EVENTS

EHA Library, Ibtesam Khalifa, 4161350

SIMILAR EFFICACY AND SAFETY OF PLASMA-DERIVED PROTEIN C CONCENTRATE BETWEEN ASIAN AND NON-ASIAN PATIENTS WITH SEVERE CONGENITAL PROTEIN C DEFICIENCY

EHA Library, Zhaoyang Li, 4161351

FEASIBILITY OF IV EPOPROSTENOL FOR ACUTE LIMB ISCHEMIA IN ANTIPHOSPHOLIPID SYNDROME: A COMPARATIVE REVIEW OF SAFETY OUTCOMES

EHA Library, George Mason, 4161352

MULTICENTER MIXED METHODS RANDOMIZED CONTROLLED TRIAL OF FEASIBILITY AND EFFICACY OF A SUPERVISED PHYSICAL ACTIVITY INTERVENTION IN MYELOPROLIFERATIVE NEOPLASMS: THE MPN-FIT TRIAL

EHA Library, Marie Ouellet, 4161353

HEALTH-RELATED QUALITY OF LIFE AND SYMPTOM BURDEN IN PRE-FIBROTIC AND OVERT MYELOFIBROSIS COMPARED TO THE GENERAL POPULATION AND PHYSICIAN PERCEPTIONS: RESULTS FROM THE GIMEMA-PROPHECY STUDY

EHA Library, Giovanni Caocci, 4161354

HEALTH-RELATED QUALITY OF LIFE BENEFITS OF FRONTLINE PONATINIB PLUS BLINATUMOMAB IN ADULT PATIENTS WITH PH+ ACUTE LYMPHOBLASTIC LEUKEMIA. PRELIMINARY ANALYSIS OF THE GIMEMA ALL2820 TRIAL

EHA Library, Laura Cannella, 4161355

PATIENT REPORTED OUTCOMES FROM BRUIN CLL-321: A RANDOMIZED PHASE 3 TRIAL COMPARING PIRTOBRUTINIB TO IDELALISIB/RITUXIMAB OR BENDAMUSTINE/RITUXIMAB IN COVALENT BTKI PRETREATED CLL/SLL

EHA Library, Paolo Ghia, 4161356

PATIENT-PHYSICIAN COMMUNICATION REGARDING TKI-RELATED ADVERSE EVENTS AND THEIR IMPACT ON QUALITY OF LIFE IN CML - INSIGHTS FROM PATIENT AND PHYSICIAN SURVEYS IN THE US

EHA Library, David Wei, 4161357

EVALUATION OF SAFETY AND GUIDELINE COMPLIANCE IN HOME RED BLOOD CELL TRANSFUSIONS: A 10-YEAR RETROSPECTIVE STUDY IN SUBURBAN TOKYO

EHA Library, Takeshi Hagino, 4161358

LONG TERM SURVIVORSHIP AFTER ALLOGENEIC HSCT: COGNITIVE IMPAIRMENT AND PSYCHOMETRIC INDICATORS AS PREDICTIVE FACTORS FOR RETURN TO WORK (NEW INSIGHTS IN THE SOPRALLO PROJECT)

EHA Library, Yana Stepanishyna, 4161359

QUALITY OF LIFE AND WORK IMPACTS AMONG CAREGIVERS OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) - A CAREGIVER SURVEY IN THE US

EHA Library, David Wei, 4161360

CHIP-RELATED MUTATIONS AS PREDICTORS OF CARDIOVASCULAR AND CEREBROVASCULAR EVENTS IN MYELOID NEOPLASMS: A RETROSPECTIVE COHORT ANALYSIS

EHA Library, Yao Wang, 4161361

A PATIENT-REPORTED OUTCOME MEASURE (PROM) TO CAPTURE PATIENTS' EXPERIENCES WITH IMMUNO-ONCOLOGY THERAPY (IO)-INDUCED CYTOKINE RELEASE SYNDROME (CRS): THE IO-INDUCED CRS PATIENT DIARY

EHA Library, Sophie Van Tomme, 4161362

MYELOMA PATIENTS' ATTITUDES AND PERCEIVED BURDEN TOWARDS TREATMENT ROUTES AND LOCATIONS: INSIGHTS FROM A EUROPEAN SURVEY

EHA Library, Eilidh Duncan, 4161363

INVESTIGATING THE KEY PREDICTORS OF QUALITY OF LIFE IN LEUKAEMIA PATIENTS: ANALYSIS OF GLOBAL STUDY DATA USING GRADIENT BOOSTED DECISION TREES.

EHA Library, Sam Salek, 4161364

HEALTH-RELATED QUALITY OF LIFE AND PREFERENCE FOR TREATMENT MODALITIES OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): RESULTS OF A REAL-WORLD STUDY

EHA Library, Alexander Röth, 4161365

PATIENT-REPORTED OUTCOMES FROM A PHASE 3, RANDOMIZED TRIAL EVALUATING THE COMBINATION OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Christopher Hartford, 4161366

SURVIVAL TRENDS AND HEALTHCARE UTILIZATION COSTS IN ACUTE MYELOID LEUKEMIA IN 2007-2022 AT THE HELSINKI UNIVERSITY HOSPITAL

EHA Library, Theerin Lanamtieng, 4161367

THE ECONOMIC IMPACT OF TREATMENT SEQUENCES FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN ITALY: A COST OF CARE SEQUENCING MODEL FOR PATIENTS WITH CLL

EHA Library, Andrea Visentin, 4161368

ECONOMIC BURDEN OF CYTOPENIA IN PATIENTS WITH MYELOFIBROSIS: ANALYSIS OF A US NATIONAL ADMINISTRATIVE CLAIMS DATABASE

EHA Library, Aaron T. Gerds, 4161369

EFFECTS OF A SUPPORTIVE ONCOLOGY CARE AT HOME INTERVENTION ON HEALTH CARE UTILIZATION IN PATIENTS WITH NON-HODGKIN LYMPHOMA: SUBGROUP ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL

EHA Library, P. Connor Johnson, 4161370

HOSPITALIZATION TIME AND TREATMENT COSTS FOR ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN). A SPANISH PETHEMA STUDY

EHA Library, Irene Navarro-Vicente, 4161371

HEALTHCARE RESOURCE UTILIZATION AND COSTS FOLLOWING THE INITIATION OF VARIOUS LINES OF THERAPY AMONG PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Adina Estrin, 4161372

FROM SWINE TO SYNTHETIC: A CLIMATE ANALYSIS ON THE SHIFT FROM HEPARIN TO APIXABAN IN POST-OPERATIVE THROMBOEMBOLISM PREVENTION.

EHA Library, Holly Cherniwchan, 4161373

INTEGRATING THE CARBON FOOTPRINT INTO HEALTH TECHNOLOGY ASSESSMENT IN FRANCE: THE EXAMPLE OF THE HEALTHCARE PATHWAY FOR CHRONIC LYMPHOCYTIC LEUKAEMIA

EHA Library, Caroline BESSON, 4161374

ACCESS TO SUTIMLIMAB FOR COLD AGGLUTININ DISEASE THROUGH THE ORPHAN DRUG ACCESS PROTOCOL IN THE NETHERLANDS: INSIGHTS FROM THE FIRST YEAR

EHA Library, Kathelijn Verdeyen, 4161375

UNDERSTANDING THE PREFERENCES OF PEOPLE WITH ACUTE LEUKEMIA FOR DIFFERENT HEALTH OUTCOMES

EHA Library, Samantha Nier, 4161376

INVESTIGATION AND MANAGEMENT OF NEUTROPENIA REFERRALS IN AREA WITH A HIGH PREVALENCE OF AFRO-CARIBBEAN PATIENTS

EHA Library, Priya Sriskandarajah, 4161377

AUTOMATED IMMUNOPHENOTYPIC PROFILING IN AML: A MACHINE LEARNING APPROACH TO EXPEDITE DIAGNOSIS AND DISEASE SUBCLASSIFICATION

EHA Library, Marco Roncador, 4161378

NONINVASIVE LONGITUDINAL DYNAMICAL PET/CT VISUALIZATION OF CAR-T CELLS VIA IN SITU BIOORTHOGONAL LABELING

EHA Library, Zhaozhao Chen, 4161379

ARTIFICIAL INTELLIGENCE-DRIVEN GHOST CYTOMETRY ENABLES LABEL-FREE DETECTION OF LEUKEMIC CELLS AND TREATMENT RESISTANCE PREDICTION IN CHRONIC MYELOID LEUKEMIA

EHA Library, Kohjin Suzuki, 4161380

CELL MARKER ACCORDION: INTERPRETABLE SINGLE-CELL AND SPATIAL OMICS ANNOTATION IN NORMAL AND ABERRANT HEMATOPOIESIS

EHA Library, Giorgia Bucciarelli, 4161381

UNSUPERVISED DEEP LEARNING REVEALS HISTOLOGICAL MOTIFS IN CD34-STAINED BONE MARROW TREPHINES OF MYELOID NEOPLASMS

EHA Library, Carlo Pescia, 4161382

NEXT GENERATION SEQUENCING FOR MINIMAL RESIDUAL DISEASE DETECTION AND MONITORING IN MULTIPLE MYELOMA: ANALYSIS OF FEASIBILITY IN DAILY PRACTICE.

EHA Library, Silvia ARMUZZI, 4161383

INTEGRATED GENOME AND EPIGENOME PROFILING OF PEDIATRIC LEUKEMIA USING NANOPORE-BASED TARGETED ADAPTIVE SAMPLING LONG-READ SEQUENCING

EHA Library, Shota Kato, 4161384

AMBIENT AI PLATFORM: AI-POWERED APPLICATION FOR CLINICAL REPORT TRANSCRIPTION ASSISTANCE AND CLINICAL TRIAL PATIENT MANAGEMENT IMPROVEMENT IN HEMATOLOGY

EHA Library, Saverio D'Amico, 4161385

HIGHLY MULTIPLEXED 2D AND 3D IMAGING UNCOVERS LEUKEMIA-INDUCED IMMUNE DYSREGULATION AND HEMATOPOIETIC DISRUPTION IN THE BONE MARROW MICROENVIRONMENT

EHA Library, Lanzhu Li, 4161386

PDT: A NOVEL DIAGNOSIS AND TREATMENT OPTION GENERATION ARCHITECTURE FOR RARE DISEASE

EHA Library, Xue Shi, 4161387

ACCURATE AND RELIABLE DETECTION OF CLONAL HEMATOPOIESIS IN PLASMA CELL-FREE DNA

EHA Library, Alyssa Parker, 4161389

ASSESSING THE UTILITY OF NGS-DETECTED CNVS AS AN ALTERNATIVE TO FISH FOR CYTOGENETIC ANALYSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Ana Gea Peña, 4161390

IMMUNOTHERAPY OF DRUG-RESISTANT HEMATOLOGIC MALIGNANCIES WITH CURE POTENTIAL BY SIMULTANEOUS TARGETING IL-2 PRE-ACTIVATED MISMATCHED T, NK & NKT CELLS AGAINST DETECTABLE CELL SURFACE CANCER ANTIGENS

EHA Library, Shimon Slavin, 4161391

AI-DRIVEN AUTOMATED LYMPHOCYTE PROFILING AND CAR-T CELL MONITORING FOR SCALABLE IMMUNOTHERAPY DIAGNOSTICS: THE SMARTCYTOFLOW PROJECT

EHA Library, Adrian Mosquera Orgeira, 4161392

GENEXUS: AN ALL-IN-ONE APPROACH OF NEXT GENERATION SEQUENCING IN THE MOLECULAR DIAGNOSIS OF ACUTE MYELOID LEUKEMIA

EHA Library, Alessandra Potenza, 4161393

LYM-SYNGAN: ENHANCING CT-TO-PET MEDICAL IMAGE SYNTHESIS FOR LYMPHOMA USING A GENERATIVE ADVERSARIAL NETWORK WITH MULTI-LEVEL LINEAR ATTENTION AND EFFICIENT VISION TRANSFORMER

EHA Library, xiangyan Feng, 4161394

LIMITATIONS OF AI-ASSISTED DIGITAL IMAGING IN DETECTING AND QUANTIFYING CIRCULATING PLASMA CELLS

EHA Library, Iona Stylianides, 4161395

REAL-WORLD POST-VOC EXPERIENCES IN SICKLE CELL DISEASE: INSIGHTS FROM UK PATIENT OUTCOMES, INSIGHTS AND WEARABLE DATA

EHA Library, Kim Summers, 4161396

OPTICAL GENOME MAPPING IS A POWERFUL DIAGNOSTIC TOOL IN NON-HODGKIN LYMPHOMA

EHA Library, Amber Verhasselt, 4161397

DEVELOPMENT OF SINGLE-MOLECULE ASSAYS FOR DETECTING BFL1 COMPLEXES TO ENABLE COMPREHENSIVE PROFILING OF THE APOPTOSIS PATHWAY

EHA Library, Hongwon Lee, 4161398

DEVELOPMENT OF AN IN VITRO BIOMARKER PLATFORM FOR DETERMINING BISPECIFIC ANTIBODY EFFICACY IN HAEMATOLOGICAL MALIGNANCIES

EHA Library, Rachel Koldej, 4161399

EXPLORING THE BELGIAN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) POPULATION THROUGH AI AND DIGITAL TECHNOLOGIES: INSIGHTS FROM THE BE-CLLEAR STUDY

EHA Library, Ann Debecker, 4161400